Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,926.00
Bid: 2,918.00
Ask: 2,920.00
Change: 63.00 (2.20%)
Spread: 2.00 (0.069%)
Open: 2,904.00
High: 2,928.00
Low: 2,887.00
Prev. Close: 2,863.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Action Capital Markets Seminar & portfolio update

18 Mar 2021 07:00

RNS Number : 6369S
3i Group PLC
18 March 2021
 

Press release

18 March 2021

 

3i Group plc

Action Capital Markets Seminar and portfolio update

 

3i will be holding a Capital Markets Seminar this morning, involving a presentation from the management team of Action, our largest portfolio company. Presentation materials will be made available on 3i's website (www.3i.com) from 09:30 today. An on-demand webcast of the seminar will also be available on our website at the end of the day.

 

The lockdown situation across Europe remains fluid and Action's trading performance in 2021 continues to reflect restrictions in a number of countries. All but 18 stores in France, and all stores in Belgium, Luxembourg, Austria and Poland are fully open and trading strongly while stores in the Netherlands, Germany and the Czech Republic are still operating under different forms of lockdown restrictions. France, Belgium, Luxembourg and Poland have traded very strongly since the start of the year with sales and EBITDA materially ahead of budget and like for likes at least 25% ahead of 2020 for the first 10 weeks of the year.

 

Action lost significant sales compared to budget in the Netherlands and Germany in January and February, although the recent relaxation of restrictions has lifted trading in March which is now moving up to budget levels in both countries. Product availability across all countries is good and the Distribution Centre network is operating well.

 

Current cash and liquidity at Action is at c. €525 million and the business is on course to open a higher number of stores in Q1 2021 than the same period last year.

 

The remainder of the Private Equity portfolio continues to demonstrate resilient performance and has significant momentum moving into the next financial year, with a number of our portfolio companies benefiting from a shift in societal trends towards e-commerce, health and hygiene and value for money retail.

 

Over the course of the financial year, we have seen a reversal in foreign exchange, as sterling has strengthened against both the euro and US dollar. As noted in our Q3 performance update, based on the balance sheet as at 31 December 2020, a 1% movement in the euro and US dollar results in a total return movement of £62 million and £13 million respectively, net of any hedging.

 

 

- Ends -

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBVRRAKUOAUR
Date   Source Headline
28th Feb 20222:47 pmRNSTotal Voting Rights
28th Feb 20222:44 pmRNSDirector/PDMR Shareholding
4th Feb 20221:08 pmRNSDirector/PDMR Shareholding
31st Jan 20225:18 pmRNSTotal Voting Rights
31st Jan 20225:16 pmRNSDirector/PDMR Shareholding
27th Jan 20227:00 amRNSQ3 Performance update
5th Jan 20225:00 pmRNSTotal Voting Rights
5th Jan 20224:58 pmRNSDirector/PDMR Shareholding
4th Jan 20229:43 amRNSPortfolio Update
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSDirectorate Change
9th Dec 202110:57 amRNSBlock listing Interim Review
30th Nov 20213:53 pmRNSTotal Voting Rights
30th Nov 20213:52 pmRNSDirector/PDMR Shareholding
30th Nov 202111:53 amRNSDirector/PDMR Shareholding
11th Nov 202111:05 amRNSDirectorate Change
11th Nov 20219:52 amRNSDoc re. Half Yearly Report 2021
11th Nov 20217:02 amRNSGroup Finance Director succession
11th Nov 20217:00 amRNSResults for the six months to 30 September 2021
3rd Nov 20211:44 pmRNSHolding(s) in Company
2nd Nov 20217:30 amRNS3i portfolio company Action announces new CEO
29th Oct 20212:29 pmRNSTotal Voting Rights
29th Oct 20212:22 pmRNSDirector/PDMR Shareholding
1st Oct 202112:59 pmRNSDirector/PDMR Shareholding
1st Oct 202110:04 amRNSPortfolio Update
30th Sep 20214:16 pmRNSTotal Voting Rights
30th Sep 20214:15 pmRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSDirectorate Change
29th Sep 20212:25 pmRNSDirector/PDMR Shareholding
28th Sep 20219:27 amRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSUpdate on portfolio and Capital Markets Seminar
21st Sep 202112:27 pmRNSDirector/PDMR Shareholding
31st Aug 20214:00 pmRNSTotal Voting Rights
31st Aug 20213:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:25 amRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSFY2022 Q1 performance update
1st Jul 20213:14 pmRNSDirector/PDMR Shareholding
1st Jul 20213:07 pmRNSDirector/PDMR Shareholding
1st Jul 202111:47 amRNSResult of AGM
1st Jul 202111:42 amRNSDoc re. AGM Resolutions
1st Jul 20219:59 amRNSPortfolio Update
30th Jun 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20214:09 pmRNSTotal Voting Rights
30th Jun 20214:04 pmRNSDirector/PDMR Shareholding
29th Jun 20212:24 pmRNSDirector/PDMR Shareholding
29th Jun 20211:55 pmRNSDirector/PDMR Shareholding
10th Jun 202110:55 amRNSBlock listing Interim Review
8th Jun 20212:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.